Clinical trial
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid…
NCT00274807 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00274807 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia |
| Official title | Intensive Induction for Newly Diagnosed Acute Myelogenous Leukemia |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cytarabine, etoposide, mitoxantrone hydrochloride |
| Enrollment | 40 |
| Start date | Jun 1, 2001 |
| Primary completion | Apr 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Jan 11, 2006 |
| Last update posted | Feb 11, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: